Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk
Despite advancements in the current standard of care, cardiovascular diseases continue to hold the top spot as the leading cause of mortality worldwide. The development of atherosclerosis is the most common culprit behind ailments such as myocardial infarction, stroke, and peripheral vascular dis...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Language: | English |
| Published: |
MDPI AG
2023
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/91202 |
| _version_ | 1848765499189493760 |
|---|---|
| author | Vaccarezza, Mauro Galassi, Francesco M |
| author_facet | Vaccarezza, Mauro Galassi, Francesco M |
| author_sort | Vaccarezza, Mauro |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Despite advancements in the current standard of care, cardiovascular diseases continue to
hold the top spot as the leading cause of mortality worldwide. The development of atherosclerosis
is the most common culprit behind ailments such as myocardial infarction, stroke, and peripheral
vascular disease. Consequently, it imposes a significant burden on life expectancy, quality of life,
morbidity, and societal costs. Both increased cholesterol levels and the activation of the inflammatory
cascade are known as cardiovascular risk facts. Their relative weight is in the spotlight of curent
biomedical research. Newly published data shed light on the role of inflammation in determining
cardiovascular risk irrespective of cholesterol levels and cholesterol-lowering therapies |
| first_indexed | 2025-11-14T11:36:13Z |
| format | Journal Article |
| id | curtin-20.500.11937-91202 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T11:36:13Z |
| publishDate | 2023 |
| publisher | MDPI AG |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-912022023-05-30T07:46:55Z Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk Vaccarezza, Mauro Galassi, Francesco M inflammation atherosclerosis cardiovascular risk statins Despite advancements in the current standard of care, cardiovascular diseases continue to hold the top spot as the leading cause of mortality worldwide. The development of atherosclerosis is the most common culprit behind ailments such as myocardial infarction, stroke, and peripheral vascular disease. Consequently, it imposes a significant burden on life expectancy, quality of life, morbidity, and societal costs. Both increased cholesterol levels and the activation of the inflammatory cascade are known as cardiovascular risk facts. Their relative weight is in the spotlight of curent biomedical research. Newly published data shed light on the role of inflammation in determining cardiovascular risk irrespective of cholesterol levels and cholesterol-lowering therapies 2023 Journal Article http://hdl.handle.net/20.500.11937/91202 10.3390/jcm12072519 English http://creativecommons.org/licenses/by/4.0/ MDPI AG fulltext |
| spellingShingle | inflammation atherosclerosis cardiovascular risk statins Vaccarezza, Mauro Galassi, Francesco M Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk |
| title | Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk |
| title_full | Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk |
| title_fullStr | Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk |
| title_full_unstemmed | Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk |
| title_short | Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk |
| title_sort | inflammation beats cholesterol: a comment on the unequivocal driver of cardiovascular disease risk |
| topic | inflammation atherosclerosis cardiovascular risk statins |
| url | http://hdl.handle.net/20.500.11937/91202 |